The European survey on Accessibility of Essential Medicines for Paediatric Malignancies

 

THE SURVEY IS NOW CLOSED. THANK YOU FOR YOUR CONTRIBUTIONS. For any queries, please contact: olga.kozhaeva@siope.eu

 

The questionnaire is an initiative of SIOPE in collaboration with CCI – Childhood Cancer International Europe, ESOP – the European Society of Oncology Pharmacy, and ESMO – the European Society for Medical Oncology.

It is part of the European project Joint Action on Rare Cancers (JARC), which aims to formulate evidence-based policy recommendations to decision-makers at national and EU levels.

The survey results will be included in the JARC outcome document presented to policy makers and can be used as a consensus statement for further advocacy efforts across Europe.

Please note that the online survey set up requires completion in one sitting and that we provide the Word versions of the questions linked below that you can use to prepare your online response. 

SIOPE thanks ESMO for allowing use of its survey questions and methodology from the ESMO studies on the availability of cancer medicines for solid adult tumours to serve as a basis for the development of SIOPE’s survey on the availability of cancer medicines for paediatric malignancies.

 

 

 


c/o BLSI
Clos Chapelle-aux-Champs 30, Bte 1.30.30
1200 Brussels
Belgium

office@siope.eu

Tel: +32 2 880 62 82